A clinical trial (BEST 3) funded by Cancer Research UK has initiated across GP surgeries in the country to evaluate the Cytosponge test developed by MRC Cancer Unit of the University of Cambridge.

The Cytosponge test is designed as a less invasive way to detect Barrett’s oesophagus, which is believed to enhance the risk of oesophageal cancer.

Aimed to identify changing oesophageal cells in patients with acid reflux symptoms, the trial will assess the ability of the test to increase the number of diagnoses in primary care.

The trial will also determine how cost-effective the test is and the willingness of patients to undergo the technique.

"Trialling a new, less invasive technique to test for Barrett’s oesophagus means that many patients each year could be saved from experiencing an endoscopy."

During the trial, a patient swallows a capsule with a sponge inside attached to a string. Upon reaching the stomach, the capsule dissolves, resulting in exposure of the sponge, which is then pulled out by the nurse. As the sponge passes up the oesophagus, it collects cells from the lining for analysis.

The trial will see enrolment of approximately 9,000 subjects aged 50 and above who are on long-term acid-suppressant medication.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Cancer Research UK's GP expert Dr Richard Roope said: "Trialling a new, less invasive technique to test for Barrett’s oesophagus means that many patients each year could be saved from experiencing an endoscopy, which can be uncomfortable.

"Around three in every 100 people with Barrett’s oesophagus go on to develop oesophageal cancer so techniques that help us to prevent or diagnose the disease earlier are vital.”


Image: Trial of Cytosponge test for Barrett’s oesophagus launches in GP surgeries across the UK. Photo: courtesy of Cancer Research UK.